Moran Wealth Management, LLC
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1965334
Naples, FL
Position in CPRX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$4,183,474
+$3,455,967 QoQ
Shares Held
168,961
+442.1% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Moran Wealth Management, LLC holds $27,467,675 across 10 Biotechnology names. CPRX ranks #2 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
175,822 | $8,434,180 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
168,961 | $4,183,474 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
19,306 | $3,854,442 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,398 | $3,398,070 | |
| 5 | EXEL |
Exelixis, Inc.
|
63,905 | $2,740,885 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
30,477 | $1,969,728 | |
| 7 | STOK |
Stoke Therapeutics, Inc.
|
40,552 | $1,320,373 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
25,302 | $1,203,616 |
All Filings in CPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,183,474 | 168,961 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $727,507 | 31,170 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $515,588 | 26,172 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $725,539 | 33,435 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $756,842 | 31,210 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $210,265 | 10,075 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||